Innovating Manufacturing Processes to Enhance Quality, Quantity & Scalability
Time: 4:00 pm
day: Day Two
Details:
- Explore how the quality threshold needed for in vivo and ex vivo therapies differs and the subsequent early manufacturing considerations that this requires
- Emphasize the importance of characterization of delivery vehicles when manufacturing, to demonstrate efficacy and safety
- Promote the early evaluation of what aspects of the workflow of gene editing therapeutic development will be challenging to scale up to ensure a more time and cost-effective transition to the clinic
